Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1998 1
1999 1
2001 2
2002 4
2003 3
2004 10
2005 23
2006 24
2007 31
2008 49
2009 49
2010 85
2011 145
2012 177
2013 193
2014 236
2015 251
2016 292
2017 318
2018 321
2019 222
2020 24
Text availability
Article attribute
Article type
Publication date

Search Results

2,176 results
Results by year
Filters applied: . Clear all
Page 1
Enhancer of zeste homolog 2 (EZH2) inhibitors.
Gulati N, B├ęguelin W, Giulino-Roth L. Gulati N, et al. Leuk Lymphoma. 2018 Jul;59(7):1574-1585. doi: 10.1080/10428194.2018.1430795. Epub 2018 Feb 23. Leuk Lymphoma. 2018. PMID: 29473431 Free PMC article. Review.
Enhancer of Zeste Homologue 2 Inhibition Attenuates TGF-╬▓ Dependent Hepatic Stellate Cell Activation and Liver Fibrosis.
Martin-Mateos R, De Assuncao TM, Arab JP, Jalan-Sakrikar N, Yaqoob U, Greuter T, Verma VK, Mathison AJ, Cao S, Lomberk G, Mathurin P, Urrutia R, Huebert RC, Shah VH. Martin-Mateos R, et al. Cell Mol Gastroenterol Hepatol. 2019;7(1):197-209. doi: 10.1016/j.jcmgh.2018.09.005. Epub 2018 Sep 15. Cell Mol Gastroenterol Hepatol. 2019. PMID: 30539787 Free PMC article.
Enhancer of zeste homolog 2 (Ezh2) controls bone formation and cell cycle progression during osteogenesis in mice.
Dudakovic A, Camilleri ET, Paradise CR, Samsonraj RM, Gluscevic M, Paggi CA, Begun DL, Khani F, Pichurin O, Ahmed FS, Elsayed R, Elsalanty M, McGee-Lawrence ME, Karperien M, Riester SM, Thaler R, Westendorf JJ, van Wijnen AJ. Dudakovic A, et al. J Biol Chem. 2018 Aug 17;293(33):12894-12907. doi: 10.1074/jbc.RA118.002983. Epub 2018 Jun 13. J Biol Chem. 2018. PMID: 29899112 Free PMC article.
Emerging EZH2 Inhibitors and Their Application in Lymphoma.
Lue JK, Amengual JE. Lue JK, et al. Curr Hematol Malig Rep. 2018 Oct;13(5):369-382. doi: 10.1007/s11899-018-0466-6. Curr Hematol Malig Rep. 2018. PMID: 30112706 Review.
Dual inhibition of enhancer of zeste homolog 1/2 overactivates WNT signaling to deplete cancer stem cells in multiple myeloma.
Nakagawa M, Fujita S, Katsumoto T, Yamagata K, Ogawara Y, Hattori A, Kagiyama Y, Honma D, Araki K, Inoue T, Kato A, Inaki K, Wada C, Ono Y, Yamamoto M, Miura O, Nakashima Y, Kitabayashi I. Nakagawa M, et al. Cancer Sci. 2019 Jan;110(1):194-208. doi: 10.1111/cas.13840. Epub 2018 Nov 16. Cancer Sci. 2019. PMID: 30343511 Free PMC article.
2,176 results
Jump to page
Feedback